Hepatitis C virus-positive donors in HCV-negative recipients in liver transplantation: Is it possible in Mexico?

J A Torres-Díaz, E A Jasso-Baltazar, L Toapanta-Yanchapaxi, J Aguirre-Valadez, L Martínez-Matínez, A Sánchez-Cedillo, D Aguirre-Villarreal, I García-Juárez
{"title":"Hepatitis C virus-positive donors in HCV-negative recipients in liver transplantation: Is it possible in Mexico?","authors":"J A Torres-Díaz, E A Jasso-Baltazar, L Toapanta-Yanchapaxi, J Aguirre-Valadez, L Martínez-Matínez, A Sánchez-Cedillo, D Aguirre-Villarreal, I García-Juárez","doi":"10.1016/j.rgmxen.2023.08.002","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients.</p>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"392-403"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de gastroenterologia de Mexico (English)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.rgmxen.2023.08.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/13 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
丙型肝炎病毒阳性供体与丙型肝炎病毒阴性受体的肝移植:在墨西哥可行吗?
丙型肝炎病毒(HCV)感染是一个全球性的公共卫生问题,发病率和死亡率都很高。在肝脏移植方面,器官供不应求,促使人们考虑将 HCV 阳性捐献者的器官用于 HCV 阴性的受者。直接作用抗病毒药物(DAAs)在根除病毒方面已显示出巨大疗效,它的问世使HCV感染供体的器官移植成为可能。本文简要回顾了目前使用 HCV 感染者器官的证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊最新文献
Clinical utility of the solid meal test during high-resolution esophageal manometry. A study in a Latin American population Rice and esophageal motility Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown are associated with the development of gastrointestinal symptoms Colorectal adenocarcinoma in children and adolescents Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1